top of page

Invest in royalties from breakthrough therapies

Unlock Early Access to Exclusive Biotech Royalty Investments

Invest Alongside The World’s Leading Institutions

logo
Logo
logo
logo
Screenshot of dashboard
Screenshot of dashboard

About BioPalace

Get rewarded for fueling medical innovation with BioPalace

Real, Measurable Patient Impact

White-Glove Support ​

Exclusive and Curated Investments​

Our mission is to democratize access to biotech royalty streams, once reserved for a few institutions, and empower a broader investor community to fund medical innovations while advancing patient care.

Venture Beyond Public Markets

Escape the unpredictability and volatility of equities by deploying your capital towards a better alternative

Industry Key Metrics

$200B+

25% IRR

Achieved by legacy biotech royalty investment firm 

~10

Institutional investors in a highly underpenetrated market

Royalty market in pharmaceuticals

45% CAGR

Growth in synthetic royalties reflects investors desire for yield, companies need for non-dilutive capital

Our Diligence Process

Our investment team is intentionally hard to please. Supported by independent legal, financial, and scientific diligence, we present only the most promising opportunities to our community of investors.

gains

Legal

We confirm ownership, permissions, scope, and payment terms, so the royalty is clean and transferable at closing

teamwork

Financial

We verify past receipts and build a conservative, easy to read forecast, so expected cash flows and timing are clear

hitting the target

Scientific

We review clinical results, real world use, and key competitors, so demand looks sustainable and patient impact is clear

Accelerate Funding, By Unlocking Your Royalties

Reach out to see how we can help fund your next milestone

Stage of Development

Why Biotech Issuers Choose BioPalace

Monetize your royalties without giving up control of your science

​

Success based fees. 100% confidential.

22.png

Fast Capital Access

23.png

Tailored Structuring

23.png

Fair Valuation

22.png

Trusted Expertise

Power of Royalty Investing

A number

Stable Income From Sales

Royalties pay as products sell, giving potential for regular cash flow, typically on a quarterly schedule

A number

Uncorrelated Returns

Cash flows track drug sales and pricing, not equity markets, which can help diversify a portfolio

A number

Attractive Risk Profile

Terms are defined up front, so exposure centers on demand and patent life, not company budgets

A number

Social Impact

Your capital supports therapies improving the lives of patients as you are rewarded with returns

A number

Inflation & Bankruptcy Protection

Royalties are paid as a % of sales, can rise with prices, and may continue through restructurings

Build Wealth, Advance Health

coins and pills

Curated biotech royalties offer more than cash flow, they can bring stability and diversification with clear terms and quarterly reporting, while helping patients and advancing human health.

​​

​

​

​

​

​

 

 

 

 

 

Get early access to our upcoming royalty investing opportunities. 

​​

Featured Offerings

Check mark

Commercial Product

Cancer

Under Review
Check mark

Commercial Product

Weightloss

Under Review
Check mark

Phase 3 Product

Heart Disease

Under Review

Getting Started

A number

Register

Create your account, complete KYC, verify accreditation, enable two factor authentication

A number

Deposit Funds

Link a bank or wire funds, held in secure escrow until closing

A number

Explore Offers

Browse vetted biotech royalties, review terms, diligence summaries, and modeled cash flows

A number

Invest and Automate

Allocate to offerings, e-sign docs, set distribution and reinvest preferences

A number

Earn Royalties and Grow Your Capital

Receive quarterly distributions, track performance in your dashboard, reinvest or withdraw

coins and pills

Meet Our Founders

1624758408289_edited.jpg

Husein Hassan

Founder 

Former Investment Banker, Private Equity Investor

  • LinkedIn
1674513566649_edited_edited.jpg

Dr. Maly Hassan

Chief Scientific Officer 

Resident, Emory University

  • LinkedIn
Logo BioPalace

Become An Investor Today

Start building wealth and advancing health.

​

Get alerts when new offerings open, and track distributions in your dashboard.

Logo BioPalace
BioPalace logo
Our Company
About
How it works
Contact
Careers
Team
Blog
FAQ

No Offer or Solicitation The information contained on this website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to invest in any securities, financial instruments, or investment products. Nothing on this website should be interpreted as a recommendation, offer, or solicitation with respect to the purchase or sale of any security or investment strategy. All securities offerings, if and when made available, will only be made pursuant to formal offering documents, such as a private placement memorandum or subscription agreement, and only to investors who qualify under applicable securities laws. Access to such opportunities is restricted to investors who are "accredited investors" as defined in Rule 501(a) of the Securities Act of 1933, as amended, and any other applicable regulations. Educational and Illustrative Purposes Only All information, content, graphics, case studies, illustrations, models, forecasts, and examples presented on this website are provided strictly for educational, illustrative, and informational purposes. They do not represent actual performance, recommendations, or guarantees of future outcomes. Any descriptions of past, expected, or illustrative performance, whether in the form of charts, data, or narratives, should not be construed as predictions of future results. Investment Risks Investments in alternative assets, including royalties, private placements, and other illiquid instruments, are speculative, carry a high degree of risk, and may result in partial or total loss of capital. No assurance can be given that investors will receive a return of their capital or that any investment objectives will be achieved. Such investments are typically illiquid and may require an indefinite holding period. Royalties and related financial instruments may be subject to unique risks, including but not limited to: market demand changes, patent or intellectual property risks, regulatory approval delays or failures, competition, default risk, counterparty risk, and macroeconomic factors. Investors should not invest unless they can afford to lose their entire investment and should not assume that investments will be profitable or liquid. No Advice Provided BioPalace does not provide investment, financial, tax, accounting, or legal advice. Nothing on this website should be construed as such advice. Investors are solely responsible for making their own independent evaluation of any potential investment, including conducting appropriate due diligence and consulting with their own legal, tax, accounting, and financial advisors. Accuracy of Information While BioPalace seeks to provide accurate, up-to-date, and reliable information, no representation or warranty, express or implied, is made regarding the accuracy, sufficiency, reliability, or completeness of any information presented on this website. BioPalace expressly disclaims any liability for errors or omissions in such information. Information provided by third parties, including issuers, is the sole responsibility of those parties, and BioPalace does not guarantee or endorse such information. Third-Party Logos, Trademarks, and Content All company names, trademarks, service marks, and logos appearing on this website are the property of their respective owners. Their appearance is for educational, informational, and illustrative purposes only and does not imply any endorsement, sponsorship, partnership, or affiliation with BioPalace. Use of such logos or marks on this website does not indicate any relationship between BioPalace and the owners of those marks. Any third-party links, references, or resources provided are for convenience only. BioPalace does not endorse, control, or assume responsibility for the content or practices of third-party websites. Forward-Looking Statements Certain statements, projections, or illustrations contained on this website may constitute "forward-looking statements." These are based on current assumptions and beliefs and are subject to risks and uncertainties that could cause actual outcomes to differ materially. No forward-looking statement is a guarantee of future performance, and reliance should not be placed on such statements. Limitation of Liability By accessing and using this website, you agree that BioPalace and its affiliates shall not be held liable for any direct, indirect, incidental, consequential, or special damages arising out of or in connection with your use of this website, reliance on its content, or participation in any investment. Your use of this website is at your own risk. User Responsibility It is the responsibility of each user to ensure compliance with applicable laws and regulations in their jurisdiction before accessing this website or considering any investment opportunities. BioPalace makes no representation that the content of this website is appropriate or available for use in all locations. Acceptance of Terms By accessing and using this website, you agree to be bound by this Disclaimer, as well as BioPalace’s Terms of Use and Privacy Policy. If you do not agree with these terms, you should not use this website.

bottom of page